Amylin Pharmaceuticals to Present at Baird Growth Stock Conference
May 12 2008 - 7:00AM
PR Newswire (US)
SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the Baird Growth Stock
Conference on Wednesday, May 14, 2008 at 3:05 p.m. CT / 1:05 p.m.
PT in Chicago. Mark G. Foletta, Senior Vice President, Finance and
Chief Financial Officer of Amylin Pharmaceuticals, will be
providing a corporate overview. The live presentation and breakout
session will be webcast, and a recording will be made available
following the event. The webcast and recording will be accessible
through Amylin's corporate website, located at
http://www.amylin.com/. To access the live webcast, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is headquartered in San Diego,
California with over 1,900 employees nationwide. Further
information on Amylin Pharmaceuticals is available at
http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Michael York, Senior Director, Investor Relations of
Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 8602 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024